The authors claim that the clinical features were not influenced by the presence of a gene mutation except for an earlier age at onset and a higher incidence of pancreatic cancer, especially in patients with a CFTR mutation (four cancer patients had CFTR mutations, one a PRSS1 mutation). The gene discussed is PRSS1; the disease is familial pancreatic carcinoma.